Although advances in pharmacotherapies for pulmonary arterial hypertension (PAH) have been realized, a percentage of PAH patients still do not…
Articles by admin
Medikidz, with the collaboration of the Imperial College Healthcare NHS Trust, has launched a comic book in a peer-reviewed series…
A new set of heart and lungs have brought renewed hope to Oswaldo Jimenez and, through the innovative approach taken…
Researchers in Turkey evaluated the two drug therapy approaches commonly used to treat pulmonary arterial hypertension (PAH) and found no substantial difference between…
Researchers from Japan described ways to predict the progression and severity of pulmonary hypertension (PH) in people with left heart…
A new study by Romanian and Belgian scientists sheds light on specific conditions associated with pulmonary hypertension (PH), and which of…
A recent article suggests prostacyclin therapy, which is used for the treatment of pulmonary arterial hypertension (PAH), may also be…
Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Letairis® (ambrisentan) with tadalafil for pulmonary arterial…
A recent study from Japan has shown that dividing cells involved in causing idiopathic pulmonary arterial hypertension (IPAH) may be…
An international group of scientists has comprehensively characterized the genetics of pulmonary arterial hypertension (PAH). This new information could ultimately…
Bellerophon Therapeutics recently announced that INOpulse, a type of nitric oxide that helps blood vessels expand, is effective in treating Pulmonary…
Reata Pharmaceuticals has announced that it will present Phase 2 results from a trial of its investigational therapy bardoxolone methyl…